SEC Form SC 13G/A filed by Nu Skin Enterprises Inc. (Amendment)

$NUS
Other Pharmaceuticals
Health Care
Get the next $NUS alert in real time by email
SC 13G/A 1 tv01576-nuskinenterprisesinc.htm SCHEDULE 13G/A nuskinenterprisesincclassa

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934
(Amendment No.: 13)*

Name of issuer:  Nu Skin Enterprises, Inc. Class A

Title of Class of Securities:  Common Stock

CUSIP Number:  67018T105

Date of Event Which Requires Filing of this Statement: December 29, 2023

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on the following page(s))

 

 

13G

CUSIP No.:  67018T105

1.  NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

The Vanguard Group - 23-1945930

2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

A. 

B.  X

3.  SEC USE ONLY

4.  CITIZENSHIP OF PLACE OF ORGANIZATION

Pennsylvania

(For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

5.  SOLE VOTING POWER

0

6.  SHARED VOTING POWER

41,347

7.  SOLE DISPOSITIVE POWER

6,119,853

8.  SHARED DISPOSITIVE POWER

95,298

9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

6,215,151

10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

N/A

11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

12.58%

12.  TYPE OF REPORTING PERSON

IA

 

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Schedule 13G
Under the Securities Act of 1934

Item 1(a) - Name of Issuer:

Nu Skin Enterprises, Inc. Class A

Item 1(b) - Address of Issuer's Principal Executive Offices:

75 West Center Street
Provo, UT 84601-4432

Item 2(a) - Name of Person Filing:

The Vanguard Group - 23-1945930

Item 2(b) – Address of Principal Business Office or, if none, residence:

100 Vanguard Blvd.
Malvern, PA 19355

Item 2(c) – Citizenship:

Pennsylvania

Item 2(d) - Title of Class of Securities:

Common Stock

Item 2(e) - CUSIP Number

67018T105

Item 3 - Type of Filing:

This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

Item 4 - Ownership:

  (a) Amount Beneficially Owned:

  (b) Percent of Class:

 

 

(c)  Number of shares as to which such person has:

(i)  sole power to vote or direct to vote:  

(ii)  shared power to vote or direct to vote:  

(iii)  sole power to dispose of or to direct the disposition of:  

(iv)  shared power to dispose or to direct the disposition of:  

Comments:

The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

Item 5 - Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

No one other person's interest in the securities reported herein is more than 5%.

Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

Not applicable

Item 8 - Identification and Classification of Members of Group:

Not applicable

Item 9 - Notice of Dissolution of Group:

Not applicable

Item 10 - Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:  February 13, 2024

By /s/ Ashley Grim
Name: Ashley Grim
Title:  Head of Global Fund Administration

Get the next $NUS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NUS

DatePrice TargetRatingAnalyst
1/31/2023$43.00 → $39.00Buy → Hold
Jefferies
2/17/2022$47.00 → $50.00Neutral
DA Davidson
11/24/2021$43.00 → $49.00Neutral
Citigroup
10/6/2021$61.00 → $47.00Neutral
DA Davidson
More analyst ratings

$NUS
Press Releases

Fastest customizable press release news feed in the world

See more
  • Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance

    Company provides initial outlook for Q1 and FY 2025 Nu Skin Enterprises Inc. (NYSE:NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Revenue $445.6 million; (8.8)% (4.1)% FX impact or $(20.1) million Rhyz revenue $83.1 million; 27.7% Earnings Per Share (EPS) $(0.73) or $0.38 excluding restructuring and other charges, compared to $0.15 or $0.37 excluding restructuring and other charges Customers 831,972; (15)% Paid Affiliates 144,874; (13)% or (12)% excluding an adjustment to eligibility requirements Sales Leaders 36,91

    $NUS
    Other Pharmaceuticals
    Health Care
  • Nu Skin Enterprises Announces Quarterly Dividend

    Nu Skin Enterprises, Inc. (NYSE:NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on March 5, 2025, to shareholders of record on Feb. 24, 2025. About Nu Skin Enterprises, Inc. The Nu Skin Enterprises Inc. (NYSE:NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by 40 years of scientific research, the company's products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, wh

    $NUS
    Other Pharmaceuticals
    Health Care
  • Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance

    Company to discuss performance, strategy and opportunities at ICR Conference; full financial results to be announced Feb. 13 Nu Skin Enterprises Inc. (NYSE:NUS) today announced Q4 2024 preliminary revenue at the high end of the company's guidance range ahead of its presentation at the ICR Conference on Tuesday, Jan. 14. President and CEO Ryan Napierski and CFO James Thomas will participate in a moderated fireside chat to discuss company strategy and the state of the business, including the recent strategic transaction of Mavely for $250 million. The company's presentation will be webcast live beginning at 3 p.m. ET. Those wishing to access the event can visit the Nu Skin investor relati

    $NUS
    Other Pharmaceuticals
    Health Care

$NUS
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$NUS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$NUS
SEC Filings

See more

$NUS
Leadership Updates

Live Leadership Updates

See more
  • Nu Skin Enterprises Appoints Mark A. Zorko to Board of Directors

    Nu Skin Enterprises (NYSE:NUS) today announced the appointment of Mark A. Zorko, a principal with executive management association Brentwood Advisory Group, to the company's board of directors. The board also appointed Zorko to serve on its audit committee and the nominating and corporate governance committee. "Mark brings extensive C-level leadership experience with several global public companies, as well as more than 20 years of board-level experience," said Steven J. Lund, executive chairman of the board. "We welcome Mark to the board and look forward to leveraging his extensive business insights and experience." Zorko is a principal with Brentwood Advisory, an association he co-found

    $NUS
    Other Pharmaceuticals
    Health Care
  • Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from

    $AAL
    $ADMA
    $ADNT
    $AMCX
    Air Freight/Delivery Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
  • Nu Skin Sets New GUINNESS WORLD RECORDS™ Title for the Most People Packing Meal Kits in 24 Hours

    To celebrate the company's 40th anniversary, sales leaders, employees and local partners packed more than 550,000 meals for children throughout the United States Nu Skin Enterprises, Inc. (NYSE:NUS), a global leader in beauty and wellness, today announced a new GUINNESS WORLD RECORDS title for the Most People Packing Meal Kits in 24 Hours. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729413403/en/Nu Skin Sets New GUINNESS WORLD RECORDS™ Title for the Most People Packing Meal Kits in 24 Hours (Graphic: Business Wire) Nu Skin hosted a service event at the Salt Palace Convention Center in Salt Lake City where 2,196 people ac

    $NUS
    Other Pharmaceuticals
    Health Care

$NUS
Financials

Live finance-specific insights

See more
  • Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance

    Company provides initial outlook for Q1 and FY 2025 Nu Skin Enterprises Inc. (NYSE:NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Revenue $445.6 million; (8.8)% (4.1)% FX impact or $(20.1) million Rhyz revenue $83.1 million; 27.7% Earnings Per Share (EPS) $(0.73) or $0.38 excluding restructuring and other charges, compared to $0.15 or $0.37 excluding restructuring and other charges Customers 831,972; (15)% Paid Affiliates 144,874; (13)% or (12)% excluding an adjustment to eligibility requirements Sales Leaders 36,91

    $NUS
    Other Pharmaceuticals
    Health Care
  • Nu Skin Enterprises Announces Quarterly Dividend

    Nu Skin Enterprises, Inc. (NYSE:NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on March 5, 2025, to shareholders of record on Feb. 24, 2025. About Nu Skin Enterprises, Inc. The Nu Skin Enterprises Inc. (NYSE:NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by 40 years of scientific research, the company's products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, wh

    $NUS
    Other Pharmaceuticals
    Health Care
  • Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance

    Company to discuss performance, strategy and opportunities at ICR Conference; full financial results to be announced Feb. 13 Nu Skin Enterprises Inc. (NYSE:NUS) today announced Q4 2024 preliminary revenue at the high end of the company's guidance range ahead of its presentation at the ICR Conference on Tuesday, Jan. 14. President and CEO Ryan Napierski and CFO James Thomas will participate in a moderated fireside chat to discuss company strategy and the state of the business, including the recent strategic transaction of Mavely for $250 million. The company's presentation will be webcast live beginning at 3 p.m. ET. Those wishing to access the event can visit the Nu Skin investor relati

    $NUS
    Other Pharmaceuticals
    Health Care

$NUS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more